{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:12:11Z","timestamp":1768615931570,"version":"3.49.0"},"reference-count":18,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,5,25]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Hypernatraemia, defined as a plasma sodium concentration &gt;145\u2009mmol\/L, is a frequent complication in critically ill patients treated in the intensive care unit (ICU) (= ICU-acquired hypernatraemia), with reported prevalence ranging from 4% to 26%. Hypernatraemia adversely affects various physiological functions and is associated with delirium, prolonged length of stay and increased ICU and post-discharge mortality. The sodium load from intravenous drug diluents significantly contributes to ICU-acquired hypernatraemia, with drug infusions comprising about 30% of the daily fluid volume of an average ICU patient. This study aims to investigate if using glucose 5% solution as the default drug diluent, instead of sodium chloride 0.9%, can reduce the prevalence of ICU-acquired hypernatraemia and improve patient outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>To test the effectiveness of glucose 5% solution as the default drug diluent, we will conduct a multicentre, pragmatic, embedded, open-label, stepped-wedge, cluster-randomised trial. The study will include twelve clusters (ICUs and one intermediate care unit) across six hospitals in Germany, with a projected total sample size of 4485 patients. In line with the stepped-wedge cluster-randomised design, one ICU will transition every 4\u2009weeks, in a randomised sequence, from using sodium chloride 0.9% as the default drug diluent to glucose 5%.<\/jats:p>\n                  <jats:p>The primary endpoint is the prevalence of hypernatraemia &gt;150\u2009mmol\/L through day 28. The number of days alive and free of the ICU through day 28 will be tested hierarchically as a key secondary endpoint. Other exploratory endpoints include ICU mortality, ICU-free days, hospital-free days and other clinical outcomes. The primary endpoint will be analysed using a logistic mixed-effects model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The trial was approved by the Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin Ethics Board and by the ethics board of each enrolled hospital. The results will be submitted for publication in a peer-reviewed journal and presented at one or more scientific conferences.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>The trial protocol was registered with the German Clinical Trials Register on 21 June 2024 prior to initiation of patient enrolment (DRKS00033397).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097361","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:25:30Z","timestamp":1749097530000},"page":"e097361","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Multicentre pragmatic embedded stepped wedge cluster randomised trial comparing glucose 5% with sodium chloride 0.9% as the default drug diluent in the ICU: the sweet-water trial protocol"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-2118","authenticated-orcid":false,"given":"Jan-Hendrik Bernhard","family":"Hardenberg","sequence":"first","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda Merle","family":"Hinz","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareen","family":"Pigorsch","sequence":"additional","affiliation":[{"name":"Institute of Biometry and Clinical Epidemiology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Uhrig","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"M\u00fcller-Redetzky","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Nee","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Trost","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Zickler","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, St Joseph Krankenhaus Berlin-Tempelhof, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Hunsicker","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjoern","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Weber-Carstens","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1062-0495","authenticated-orcid":false,"given":"Claudia","family":"Spies","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Tampe","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, Gottingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-745X","authenticated-orcid":false,"given":"Rainer","family":"Borgstedt","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Medical Center OWL Bielefeld University, Campus Bielefeld-Bethel, Bielefeld, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Abu-Tair","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Medical Center OWL Bielefeld University, Campus Bielefeld-Bethel, Bielefeld, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-1714","authenticated-orcid":false,"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, Munster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Strau\u00df","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, Munster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Schenk","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Hildebrand","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"von Wedel","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6789-8471","authenticated-orcid":false,"given":"Felix","family":"Balzer","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Enghard","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"German Rheumatism Research Center Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2025071022152113000_15.6.e097361.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422006"},{"key":"2025071022152113000_15.6.e097361.2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcrc.2012.05.001","article-title":"Hypernatremia in critically ill patients","volume":"28","author":"Lindner","year":"2013","journal-title":"J Crit Care"},{"key":"2025071022152113000_15.6.e097361.3","doi-asserted-by":"crossref","DOI":"10.1136\/tsaco-2020-000564","article-title":"Incidence and risk factors of delirium in surgical intensive care unit","volume":"6","author":"Ali","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"key":"2025071022152113000_15.6.e097361.4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9093017","article-title":"ICU-Acquired Hypernatremia Is Associated with Persistent Inflammation, Immunosuppression and Catabolism Syndrome","volume":"9","author":"Rugg","year":"2020","journal-title":"J Clin Med"},{"key":"2025071022152113000_15.6.e097361.5","article-title":"Association Between ICU-Acquired Hypernatremia and In-Hospital Mortality: Data From the Medical Information Mart for Intensive Care III and the Electronic ICU Collaborative Research Database","volume":"2","author":"Olsen","year":"2020","journal-title":"Crit Care Explor"},{"key":"2025071022152113000_15.6.e097361.6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcrc.2012.11.013","article-title":"Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay","volume":"28","author":"Waite","year":"2013","journal-title":"J Crit Care"},{"key":"2025071022152113000_15.6.e097361.7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2044.2008.05857.x","article-title":"Acquired hypernatraemia is an independent predictor of mortality in critically ill patients","volume":"64","author":"O\u2019Donoghue","year":"2009","journal-title":"Anaesthesia"},{"key":"2025071022152113000_15.6.e097361.8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm831"},{"key":"2025071022152113000_15.6.e097361.9","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000773"},{"key":"2025071022152113000_15.6.e097361.10","first-page":"306","article-title":"Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion","volume":"10","author":"Apte","year":"2008","journal-title":"Crit Care Resusc"},{"key":"2025071022152113000_15.6.e097361.11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcrc.2016.11.035","article-title":"Hydrochlorothiazide in intensive care unit-acquired hypernatremia: A randomized controlled trial","volume":"38","author":"van IJzendoorn","year":"2017","journal-title":"J Crit Care"},{"key":"2025071022152113000_15.6.e097361.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.04.015"},{"key":"2025071022152113000_15.6.e097361.13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00134-018-5147-3","article-title":"Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population","volume":"44","author":"Van Regenmortel","year":"2018","journal-title":"Intensive Care Med"},{"key":"2025071022152113000_15.6.e097361.14","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-020-00489-6","article-title":"Saline versus 5% dextrose in water as a drug diluent for critically ill patients: a retrospective cohort study","volume":"8","author":"Aoyagi","year":"2020","journal-title":"J Intensive Care"},{"key":"2025071022152113000_15.6.e097361.15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/CCM.0000000000003191","article-title":"Insidious Harm of Medication Diluents as a Contributor to Cumulative Volume and Hyperchloremia: A Prospective, Open-Label, Sequential Period Pilot Study","volume":"46","author":"Magee","year":"2018","journal-title":"Crit Care Med"},{"key":"2025071022152113000_15.6.e097361.16","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae328","article-title":"Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients","volume":"17","author":"Hardenberg","year":"2024","journal-title":"Clin Kidney J"},{"key":"2025071022152113000_15.6.e097361.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025071022152113000_15.6.e097361.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-2050CP"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:15:40Z","timestamp":1752210940000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2024-097361"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097361","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}